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Abstract 
Multicellular 3-dimensional (3D) in vitro models of normal human breast tissue to 
study cancer initiation are required. We present a model incorporating three of the 
major functional cell types of breast, detail the phenotype and document our breast 
cancer initiation studies. Myoepithelial cells and fibroblasts were isolated and 
immortalised from breast reduction mammoplasty samples. Tri-cultures containing 
non-tumorigenic luminal epithelial cells HB2, or HB2 overexpressing different HER 
proteins, together with myoepithelial cells and fibroblasts were established in 
collagen 1. Phenotype was assessed morphologically and immunohistochemically 
and compared to normal breast tissue. When all three cell types were present 
polarised epithelial structures with lumens and basement membrane production were 
observed, akin to normal human breast tissue. Overexpression of HER2 or HER2/3 
caused a significant increase in size, while HER2 overexpression resulted in 
development of a DCIS-like phenotype. In summary, we have developed a 3D tri-
cellular model of normal human breast, amenable to comparative analysis after 
genetic manipulation and with potential to dissect the mechanisms behind the early 
stages of breast cancer initiation. 
 
Keywords: 3D cell culture, breast, HER2  
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Introduction 
Researchers are beginning to appreciate the need for more complex multicellular 
three-dimensional (3D) laboratory models in order to study the processes associated 
with disease progression.  In recent years there has been a shift towards developing 
3D in vitro models that better represent breast tissues. These typically involve 
culturing breast epithelial cells alone or with fibroblasts [1-3] in 3D in the presence of 
extracellular matrix (ECM) such as MatrigelTM or collagen I. Mammary luminal 
epithelial cells respond to ECM by forming acini-like structures [4]. By culturing cells 
with specific ECM constituents, cell-cell and cell-ECM interactions can be 
represented in the laboratory [5]. This has led to a better understanding of how 
different breast cell types interact with each other and the surrounding ECM as well 
as identification of key intercellular signalling proteins involved in maintaining luminal 
cell polarity such as integrins [6] and cadherins [7].  
Current 3D in vitro models of normal human breast are limited. Compared to the 
wealth of breast cancer cell lines available to represent the molecular subtypes of 
breast cancer [8], normal breast epithelial cell lines are scarce. MCF10A is the most 
commonly used cell line to represent normal breast. When cultured in MatrigelTM, 
polarised acini-like structures with hollow lumens develop which produce basement 
membrane proteins [9, 10]. These models often incorporate fibroblasts [1-3]. 
However, MCF10A cells have a propensity to adopt a basal phenotype [11, 12] and 
are sensitive to changes in culture conditions [13] making them challenging to work 
with. Furthermore there are limitations to using MatrigelTM; although used widely, the 
levels of growth factors and basement membrane components are heterogeneous 
[14] and the substance itself is prepared from Engelbreth-Holm-Swarm mouse 
sarcoma cells. The main constituent of breast stroma is collagen I [15] a regulator of 
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morphology and phenotype of breast epithelial cells [1, 16, 17]. Moreover, variation 
in the amount of collagen and subsequent mammographic density may be linked to 
the onset of breast cancer [18, 19]. Thus the case for incorporating collagen I in the 
development of 3D in vitro models of breast tissue is strong.  
In addition to the role fibroblasts play in regulating luminal epithelial behaviour [20-
22], breast myoepithelial cells are important in maintaining luminal epithelial 
polarisation and architecture [23, 24]. These are considered tumour suppressive [25, 
26], expressing a number of tumour suppressor proteins e.g. maspin DQG (5ȕ, 
structural ECM proteins e.g. fibronectin, proteinase inhibitors e.g. tissue inhibitor of 
metalloproteinase-1 (TIMP1) and angiogenic inhibitors e.g. thrombospondin-1 [25, 
27, 28]. However, studies incorporating these cells into 3D models are limited.  
This study aimed to create in vitro a 3D tri-culture system of normal human breast 
that incorporates an alternative normal luminal epithelial cell line HB2 [29, 30], 
together with myoepithelial and fibroblast cells in a physiologically relevant matrix, 
collagen I.  We demonstrated that the model is representative of normal human 
breast by comparing the morphology and immunoprofile to µJROG VWDQGDUG¶ normal 
human breast tissue sections, and determined that the model was amenable to 
cancer initiation studies through HER overexpression in luminal epithelial cells. 
Materials and Methods 
Tissue 
Reduction mammoplasty samples were collected with informed consent via the 
Leeds Breast Cancer Campaign Tissue Bank following ethical approval (REC: 
09/H1306/108, 10/H0308/48).  
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Cell culture 
The non-tumorigenic breast epithelial HB2 cell line used [31]. The myoepithelial cell 
line Myo1089 was derived from breast reduction mammoplasty tissue and 
transduced with SV40 large T antigen [2] (gLIW IURP3URIHVVRU0LNH2¶+DUHLudwig 
Institute, London, UK). HB2 cells overexpressing HER2 and HER3 were generated 
through transfection of pSV2-HER2 [32] or retroviral transduction  of pLXSN-ErbB3 
[33], followed by single-stain or double-stain fluorescence activated cell sorting 
(FACS) for HER2 and HER3 or HER2/3 overexpressing cells, respectively to isolate 
>95% pure cell populations. Fibroblasts were isolated from breast reduction 
mammoplasty tissue [34] and retrovirally transduced with pBABE-neo-hTERT [35] to 
increase longevity. Quarterly mycoplasma tests were consistently negative. With the 
exception of fibroblasts isolated in-house, all cells were Short Tandem Repeat 
profiled annually by the Leeds Institutes of Molecular Medicine Genomics facility 
confirming no cross-contamination (last tested April 2014).  
Western blotting 
This was performed as previously [34] using NuPAGE® Novex® 4-12% Bis-Tris Gels 
(Invitrogen, Carlsbad, CA, USA) and proteins transferred to polyvinylidene difluoride 
membrane (Amersham Biosciences, Buckinghamshire, UK). Membranes were 
incubated (4oC overnight) with HER2 IgG (Rabbit Polyclonal, Cell Signalling 
Technology, dilution 1:1000), HER3 IgG (Mouse monoclonal, Clone 2F12, Millipore, 
dilution 1:1000) or ȕ-actin IgG (Clone AC-15, Sigma, dilution 1:10000) and HRP 
conjugated secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, USA; 
dilution 1:10000; 1 hr) before visualisation  with SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Scientific, Loughborough, UK). 
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3D collagen gel culture 
Myo1089 cells and fibroblasts were fluorescently labelled with pGIPZ-tGFP and 
pFURW-dsRed lentiviral vectors respectively and generated using a 2nd generation 
lentiviral packaging system to enable tracking in culture [36] (Suppl Figure 1).  Rat 
Tail Collagen I (BD Biosciences, USA) was diluted with Dulbecco¶s Phospho 
Buffered Saline (DPBS, Invitrogen, Carlsbad, CA, USA; 2mg/mL [2] and mixed with 
eight parts of collagen solution (2mg/mL) to one part 10x Hanks Buffered Salt 
Solution (HBSS, Sigma, Poole, UK). The gel was neutralised by drop-wise addition 
of NaOH until a pink-orange colour was achieved. 3D gel culture medium was 
prepared (50% complete HAMF12 Nutrient Mixture (Sigma, Poole, UK); 50% 
complete DulEHFFR¶V PRGLILHG (DJOH¶V PHGLXP (DMEM, Invitrogen, Carlsbad, CA, 
USA)). Myo1089, HB2 and fibroblast cells were mixed (6:2:1, respectively) in one 
volume of the above media to achieve a cell density of 4x105 cells /mL gel. 200µl of 
the gel-cell mixture was added to 12-well plate Transwell® cell culture inserts with 
PET membranes and 8.0µm pore size (BD Falcon®, USA) and placed within wells of 
a culture plate (Costar, Corning Inc, Corning, USA). Gels were allowed to solidify (20 
mins 37oC in 5% CO2) before adding 500µl of media to the top of each gel-
containing and 1mL to the bottom of each well in the cell culture plate. Gels were 
cultured for 21 days with 50% of the media being replaced every three days during 
this time. Gels were fixed in 10% formalin (Sigma, Poole, UK) for 5 hours, processed 
(Leica ASP 200 tissue processor), paraffin embedded and 5µm sections taken using 
a Leica RM2235 microtome (both Leica Microsystems, Milton Keynes, UK) and 
mounted onto Superfrost Plus slides (BDH, Poole, UK). All slides were H&E stained 
allowing visualisation. 
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Immunohistochemistry  
This was performed on 5µm sections from reduction mammoplasty tissue and 3D 
gels. Primary antibodies included: vimentin (Clone Vim 3B4, 1:200), epithelial 
membrane antigen (EMA; Clone E29, 1:5000), Į-smooth muscle actin (Į60$Clone 
1A4, 1:200), E-cadherin (Clone NCH-38, 1:100), Ki67 (Clone MIB1, 1:1000) [all 
Dako, Glostrup, Denmark], collagen IV (Clone COL-94, 1:100, Sigma, Poole, UK], 
M30 (mouse anti-human monoclonal, Clone M30, 1:50, Roche Diagnostics, West 
Sussex, UK), turboGFP (rabbit polyclonal, 1:500, Pierce, Northumberland, UK) and 
dsRed (rabbit polyclonal, 1:200, Clontech Laboratories Inc, CA, USA). Primary 
antibody omission served as negative controls in each run. Antibodies were 
incubated overnight at 4oC with the exception of turboGFP and dsRed (2 hours, 
room temperature). Heat-induced antigen retrieval was used with the exception of 
those incubated with collagen IV which required proteolytic antigen retrieval.  Here, 
sections were incubated at 37oC for 20 mins in 20µg/mL Proteinase K (Fungal, 
Invitrogen, Carlsbad, CA, USA) in Phosphate Buffered Saline (PBS) prior to 
blocking. An extra blocking step was used prior to antibody incubation; sections were 
rinsed twice with 2% Bovine Serum Albumin (BSA, Sigma, Poole, UK) in PBS before 
adding 100µl 20% goat serum (Dako, Glostrup, Denmark) in PBS incubation at room 
temperature for 20 mins).  
Image acquisition  
Slides were scanned (Aperio CS and AT scanners; Aperio Technologies Inc, Vista, 
CA, USA) using x20 and x40 objectives producing images with a final resolution of 
0.23 and 0.43µm per pixel respectively. Digital images were acquired using Aperio 
Imagescope software version 11. 
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Quantification of 3D in vitro tri-culture model 
Annotation tools were used to outline the perimeters of the whole gel section from 
digital images at 20x magnification, any holes within the gel section and around HB2 
units were excluded manually using a computer equipped with a Wacom Cintiq 
touchscreen monitor. A viable co-unit was defined as a cohesive cluster of four or 
more cells with discernible nuclei. To ensure that units quantified were comprised of 
HB2 cells, IHC was performed alongside H&E of the gels to confirm that the 
structures being annotated did not contain turboGFP or dsRed positive cells. co-unit 
on the periphery of the gel section or holes were excluded as they did not represent 
the majority of co-units within the gels (Suppl Figure 2). Aperio Imagescope software 
calculated the number of annotations drawn and area of each annotation in µm2. 
Lumen formation was defined as a space within co-units that was enclosed by a 
continuous chain of cells and was counted manually. Any co-units that contained 
luminal spaces with breaches in the surrounding cells were excluded (Suppl Figure 
3). The area of the gel section was calculated by subtracting the area of holes in the 
gel from the total area of the gel section. Due to the inherent variation between the 
size of gel sections and therefore the number of co-units within each gel, the area of 
co-units were normalised by expressing the area of the unit per µm2 of gel. This was 
calculated by taking the area of each co-unit and dividing by the area of the gel 
section. For each experiment, one section from three replicate gels for each variable 
was quantified. Raw data was inputted into GraphPad Prism 6 software where the 
mean and SEM was calculated along with statistical analysis. For comparison of the 
area, number and lumen formation, unpaired t-test analysis was performed where 
p<0.05 was considered significant. 
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Results 
3D in vitro tri-culture model recapitulates the morphology and phenotype of 
normal human breast tissue  
HB2 cells were cultured alone, with Myo1089 cells or with Myo1089 and fibroblasts 
in collagen I gels and phenotype assessed by H&E after 21 days. When cultured 
alone, HB2 cells formed tight spherical units of varying size with occasional scattered 
cells (Figure 1a, b). A similar phenotype was observed when HB2 were co-cultured 
with Myo1089 cells (Figure 1c, d). Tri-culture of HB2, Myo1089 and fibroblasts, 
resulted in the arrangement of Myo1089 myoepithelial cells around the outer edges 
of spherical lumen containing HB2 epithelial cells with fibroblasts loosely distributed 
throughout the collagen gel (Figure 1e) akin to normal breast acini (Figure 1f). This 
phenotype was only observed when all 3 cell types were present. 
We then conducted immunohistochemical characterisation of 3D in vitro tri-cultures 
and compared this to normal human breast tissue. As shown in Figure 2, tri-culture 
phenotype (a-d, h-k) was strikingly similar to that of normal breast tissue (d-g, l-p). 
Controls (no primary antibody) are shown in Figure 2a and d. E-cadherin (E-cad) 
was expressed at cell-cell junctions (Figure 2b, e) with EMA at apical membranes 
(Figure 2c, f). Some cell proliferation was identified by Ki67 staining (Figure 2d, g), 
with apoptosis detected within central lumens by M30 staining (Figure 2h,l)Į-SMA 
was specific to myoepithelial cells (Figure 2i, m) while basement membrane 
production was detected around outer edges of breast ducts by collagen IV 
expression (Figure 2j, n). Vimentin expression was detected in both myoepithelial 
cells and fibroblasts (Figure 2k, p). Comparison of these immunohistochemical 
features to normal breast tissue sections demonstrated strikingly strong similarities.  
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Overexpression of HER proteins affect the morphology and phenotype of the 
tri-culture model 
To test whether the tri-culture model was suitable for cancer initiation studies, HER2 
and HER3 proteins were overexpressed in HB2 cells. Protein presence was 
confirmed by western blot analysis (Figure 3a). Compared to controls (Figure 3b) 
upon HER2 overexpression, HB2 cells formed larger, elongated units with distorted 
lumens and the appearance of protrusions from outer edges (Figure 3c).  HER3 
overexpressing cells also formed larger units containing distorted lumens but 
retained a spherical shape (Figure 3d). HB2 cells overexpressing both HER2 and 
HER3 formed a combination of smaller rounded units and larger elongated units that 
were larger than HB2 controls and also featured distorted lumens (Figure 3e). 
Quantitative analysis supported these observations. HB2 co-units significantly 
increased in size following HER2, or HER2/3 overexpression (Figure 3f, p=<0.05). 
Overexpression of HER3 induced a significant decrease (Figure 3g, p=0.0442) in co-
unit formation, while overexpression of HER2, HER3 and HER2/3 caused a 
decrease in lumen formation compared to HB2 controls (Figure 3h, p=<0.05). 
HER2 overexpressing HB2 3D tri-cultures resemble human DCIS phenotype  
H&E stained sections of HER2 overexpressing and HB2 control 3D tri-cultures were 
compared with a cross section of a human breast tissue that contained areas of both 
DCIS and normal adjacent acini (Figure 4a). As previously, HB2 control units were 
small, rounded, contained lumens (Figure 4b) and were similar phenotypically to 
normal breast acini (Figure 4a). In the breast tissue section, areas of DCIS featured 
large elongated ducts and contained distorted lumens with necrotic tissue (Figure 
4a). These also contained enlarged and discohesive cells. HER2 overexpressing 
HB2 units were similarly elongated in shape, containing discohesive cells with 
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distorted luminal spaces thought to be a product of necrosis (Figure 4c). This not 
only confirmed that the normal 3D tri-culture model was robust and retained features 
of normal breast acini, but also that morphological features of DCIS could be 
recapitulated through overexpression of HER2 in the 3D tri-culture model.  
Discussion 
With scientists now recognising the importance of the microenvironment in cancer 
initiation and progression, there is an increased need for robust 3D in vitro models 
which incorporate components of the microenvironment. Here, we present, a 3D in 
vitro model of normal human breast that incorporates not only breast luminal 
epithelium with fibroblasts, but also myoepithelial cells all embedded in the 
physiologically relevant matrix collagen I. This model reflects the morphology and 
phenotype of normal breast providing a novel tool to investigate the mechanisms 
behind the early events of cancer initiation and the formation of pre-malignant 
lesions. 
Following optimisation of culture conditions including culture medium, cell numbers 
and duration of culture (data not shown), we demonstrated that co-culturing the three 
major cell types comprising the mammary duct in collagen I resulted in the 
arrangement of a border of myoepithelial cells surrounding HB2 epithelial cells which 
formed ductal structures with hollow lumens, with fibroblasts loosely distributed 
throughout the collagen gel. This morphology was remarkably similar to µgold 
standard¶ normal human breast acini.  
This was confirmed further by immunohistochemical analysis of a panel of breast 
epithelial and mesenchymal markers and expression profiles compared to normal 
breast tissue. Near-identical expression patterns provided confidence that our 3D in 
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vitro tri-culture model was a robust model of normal human breast tissue. Deposition 
of basement membrane protein collagen IV around the outer edges of co-units was 
observed, supporting previous reports that inclusion of myoepithelial cells with 
luminal epithelial cells in 3D collagen I matrix can abrogate the need for basement 
membrane preparations such as MatrigelTM [24] due to their ability to produce 
proteins required for basement membrane formation [25]. All co-units displayed E-
cadherin expression between HB2 cell junctions with epithelial membrane antigen 
situated at the apical-luminal interface of HB2 cells indicating the polarisation of HB2 
cells. The presence of lumens cleared via apoptosis as detected by M30 expression. 
In addition, we proved that each cell type retained a phenotype representative of 
their corresponding cell type in normal breast tissue with vimentin expression 
detected in Myo1089 and fibroblastVDQGĮ-smooth muscle actin found in Myo1089 
cells only. Continued correlation to normal human breast tissue supports the validity 
of the tri-cultures as models of normal breast acini. 
We then sought to determine if the model could be used as a tool to study cancer 
initiation processes. Focussing on the luminal epithelium, we aimed to disrupt the 
normal architecture to produce a morphology and phenotype akin to early pre-
malignant breast lesions, through overexpression of HER proteins. HER2 gene 
amplification and protein overexpression is observed in around 16% of breast 
cancers [37] and is associated with a poor prognosis and survival in breast cancer 
patients due to its relationship with more aggressive tumours [38]. HER2 
overexpression also occurs in up to 50% of DCIS [39] suggesting a role in cancer 
initiation with murine studies demonstrating HER2 overexpression alone is sufficient 
to induce transformation of mammary epithelium in a single step [40, 41]. This 
demonstrates the potency of HER2 as an oncogene. The HER2-HER3 heterodimer 
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is the most potent and mitogenic heterodimer of the HER family. The potential of the 
HER2-HER3 heterodimer to activate PI3K [42] and the MAPK pathway [43, 44] 
makes HER2 a key regulator of a variety of cell responses such as proliferation, 
apoptosis and differentiation. Our study demonstrated that overexpression of HER2 
alone had the most dramatic effect on the architecture of co-units. These were 
significantly larger; more elongated, and featured protrusions similar to DCIS. 
Furthermore, lumen formation was significantly reduced within these co-units. This 
correlated with reports suggesting HER2 and HER3 overexpression induced 
increased proliferation and lumen filling in MCF10A cells [45-47]. In our model, these 
features were less pronounced with HER3 overexpression alone or with a 
combination of HER2/HER3 overexpression suggesting that the HER2-HER3 
heterodimer was not the most potent inducer of aberrant epithelial architecture in the 
tri-culture model. However, since the effects of HER overexpression on luminal 
epithelial architecture has not been studied in the presence of both myoepithelial 
cells and fibroblast before, the effects of HER overexpression may be context 
dependent i.e. due to differences in the luminal cell microenvironment. 
Phenotypically, HER2 overexpressing tri-cultures had a strikingly similar phenotype 
to DCIS. Features such as elongated shape, distorted lumens, the presence of 
discohesive cells and necrosis were all recapitulated upon overexpression of HER2 
in the model. The ability to produce structures that reflect early pre-malignant lesions 
such as DCIS in a physiologically relevant context validated the suitability of our 
model for cancer initiation studies. 
In summary we have successfully produced a robust heterotypic 3D in vitro model of 
normal human breast tissue that incorporated the three major cell types found in the 
breast in a physiologically relevant matrix of collagen I. We demonstrated individual 
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cell populations were traceable, and formed co-units which shared morphology and 
phenotype with breast acini of the normal human mammary gland. The model is 
robust, amenable to genetic manipulation and can be analysed and quantified by 
standard laboratory techniques. Our vitro model could be used to dissect the 
mechanisms behind the early stages of breast cancer initiation.  
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Figure legends 
 
Figure 1 
Comparison of morphology of 3D tri-culture model with normal human breast 
tissue  
When cultured alone (a,b), HB2 cells formed tight spherical units of varying size with 
occasional scattered cells. A similar phenotype was observed when HB2 were co-
cultured with Myo1089 cells (c, d). In tri-cultures containing HB2, Myo1089 and 
fibroblasts, ductal structures with hollow lumens (dotted arrow) were observed 
surrounded by a border of clear myoepithelial cells (arrow; e) akin to normal human 
breast acini (f).  Scale bars = 100µm 
 
Figure 2 
Comparison of immunohistochemical profiles of 3D tri-cultures with those of 
normal breast tissue 
The phenotype of 3D in vitro tri-cultures (a-d; h-k) was assessed by 
immunohistochemistry and compared to cross sections of breast reduction 
mammoplasty tissue (d-g; l-p). Negative controls (a, d). E-cadherin was expressed 
by HB2 epithelial cells at cell-cell junctions (b, arrow) similar to luminal epithelium of 
breast acini (e, arrow). EMA expression was concentrated at the HB2 cell-lumen 
interface in co-units (c) and was specific to apical membranes of luminal epithelium 
of breast acini (f, arrow).The majority of cells within HB2 co-units expressed Ki67 (d) 
with scattered positivity within breast acini (g). M30 staining demonstrated apoptosis 
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within lumens of HB2 co-units (h, arrow) and also in breast acini (l, arrow). Į-SMA 
was restricted to myoepithelial cells on the periphery of HB2 co-units (i, arrow) while 
DFRQWLQXRXVOD\HURIĮ-SMA positive myoepithelial cells surround luminal epithelium 
of breast acini (m, arrow).Collagen IV was concentrated around outside edges of 
HB2 co-units (j, arrow) and similarly is demonstrated encapsulating breast acini (n, 
arrow). Vimentin was expressed in both Myo1089 cells (M) and fibroblasts (F) in the 
tri-culture model (k) analogous to Vimentin positivity in myoepithelial cells (M) and 
fibroblasts (F) in normal breast tissue (p). Original magnification for tri-culture model 
= 20x; for normal tissue = 40x.  
 
Figure 3 
Overexpression of HER proteins in HB2 cells affects 3D architecture  
Stable overexpression of HER2 and HER3 in HB2 cells was shown by western blot 
(a). WT cells in 3D tri-culture (b) formed rounded units (RU) with lumens (L). When 
HER2 was overexpressed (c), formation of much larger elongated units (EU) with 
distorted lumens (DL) and protrusions (PRO) from edges was observed. HER3 
overexpression (d) resulted in rounded units with distorted lumens (DL) while 
overexpression of HER2 and HER3 cells (e) resulted in a combination of rounded 
units (RU) and elongated units (EU) with distorted lumens (DL). Quantitative analysis 
confirmed HER2 and HER2/3 overexpression induced significantly larger HB2 unit 
formation (f). Only HER3 overexpression alone significantly altered the number of 
HB2 units formed (g) while HER2, HER3 and HER2/3 overexpression significantly 
reduced lumen formation (h). Bars denote mean from three gel replicates and error 
bars standard error of the mean (SEM). * = p<0.05 
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Figure 4 
Comparison of HER2 overexpressing tri-cultures to human breast tissue 
containing DCIS  
 A cross section of human breast tissue (a) shows normal acini which are small and 
rounded with cleared central lumens (L, inset). Areas of DCIS consist of elongated 
discohesive cells (DC) with distorted lumens containing necrotic cells (DL). Co-units 
of the tri-culture model are also small and rounded with central lumens (L), strongly 
resembling normal breast acini. Overexpression of HER2 in luminal epithelium (c) 
resulted in an elongated, branched shape, the appearance of distorted lumen with 
possible necrosis (DL) and also discohesive cells (DC), reminiscent of a DCIS-like 
phenotype. Original magnification x20 (tri-culture model); 40x (breast tissue).  
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